Evidence map›Paper›PMID 35338491›Full record

ArticleJournal of medical virology2022

Melatonin use for SARS-CoV-2 infection: Time to diversify the treatment portfolio.

Russel J Reiter, Ramaswamy Sharma, Dun-Xian Tan, Richard L Neel, Fedor Simko, Walter Manucha, Sergio Rosales-Corral, Daniel P Cardinali

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Access to the COVID-19 Vaccine.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Russel J ReiterDepartment of Cell Systems and Anatomy, Long School of Medicine, UT Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0001-6763-4225
Ramaswamy SharmaDepartment of Cell Systems and Anatomy, Long School of Medicine, UT Health San Antonio, San Antonio, Texas, USA.
Dun-Xian TanDepartment of Cell Systems and Anatomy, Long School of Medicine, UT Health San Antonio, San Antonio, Texas, USA.
Richard L NeelAlcasian Care Enterprises, Castroville, Texas, USA.
Fedor SimkoFaculty of Medicine, Institute of Pathophysiology, Comenius University, Bratislava, Slovak Republic.
Walter ManuchaÁrea de Farmacología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
Sergio Rosales-CorralCentro de Investigacion Biomedica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.
Daniel P CardinaliFaculty of Medical Sciences, Pontificia Universidad Católica Argentina, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentMelatoninAntioxidantsAntiviral AgentsHumansSARS-CoV-2AntioxidantsAntiviral AgentsMelatonin

Identifiers

PMID35338491
PMCPMC9088493

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.